Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Vox Announces Pricing of $55 Million Underwritten Public Offering of Common Shares
-
Eupraxia Pharmaceuticals closes $80.5 million public offering
-
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
-
Cantor Fitzgerald Reiterates Overweight Rating on Cabaletta Bio Inc. (CABA)
-
SPS Commerce (SPSC) PT Lowered to $135 at Cantor Fitzgerald
-
Micron Technology (MU) PT Raised to $200 at Cantor Fitzgerald
-
MercadoLibre (MELI) PT Raised to $2,900 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Neutral Rating on Alphabet (GOOGL)
-
Lucid Group Inc. (LCID) PT Raised to $26 at Cantor Fitzgerald
-
Vox Royalty acquires $57.5 million global gold portfolio
-
Vox Royalty Announces Agreement to Acquire Transformational Global Gold Portfolio, Overnight Marketed Offering of Common Shares and Expanded Revolving Credit Facility
-
Brera Holdings PLC (NASDAQ: BREA) Closes ~USD $300 Million PIPE Financing
-
BioFuture™ 2025 Explores the Next Era of Innovation, Policy, and Investment in Biopharma
-
Cantor Fitzgerald Reiterates Overweight Rating on Alector Inc. (ALEC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Firefly Aerospace Inc (FLY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Crinetics (CRNX)
-
Cantor Fitzgerald Reiterates Neutral Rating on Marti Technologies (MRT)
-
Eupraxia Pharmaceuticals prices $70 million public offering at $5.50 per share
-
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares
-
Eupraxia Pharmaceuticals announces proposed public offering of common shares
-
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
-
Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings
-
Strive agrees to acquire Semler Scientific in all-stock deal
-
Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction
-
SunPower to acquire Sunder Energy for $40M cash plus shares
-
SPWR to Acquire Sunder Energy to Gain U.S. No. 5 Spot
-
Cantor Fitzgerald Starts CytomX Therapeutics (CTMX) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Pharmaceuticals (RCKT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Cantor Fitzgerald Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)
-
Cantor Fitzgerald Reiterates Overweight Rating on uniQure BV (QURE)
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Nano-X Imaging (NNOX)
-
Zenith Securities Rising: New Ownership Launches Next Chapter for Institutional Investment Bank
-
Brera Holdings secures $300 million funding to transform into Solana treasury
-
Wall Street Finds Its Solmate: Brera Holdings PLC (NASDAQ: BREA) Announces Oversubscribed $300 Million Private Placement to Fund Establishment of Solana Digital Asset Treasury Backed by Ark Invest and
-
Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Arvinas Inc. (ARVN)
-
CrowdStrike Holdings (CRWD) PT Raised to $500 at Cantor Fitzgerald
-
monday.com Ltd. (MNDY) PT Lowered to $257 at Cantor Fitzgerald
-
Bullish (BLSH) PT Raised to $59 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on MongoDB (MDB)
-
Cantor Fitzgerald Reiterates Neutral Rating on Zoom Video (ZM)
-
Form 424B3 Cantor Fitzgerald Income
-
Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Metsera Inc (MTSR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Structure Therapeutics (GPCR)
-
Cantor Fitzgerald Reiterates Overweight Rating on DoorDash Inc. (DASH)

